NCF4 (Neutrophil Cytosolic Factor 4)

Migration, Crosslink

📖

NCF4 (Neutrophil Cytosolic Factor 4)

active

wiki page Created: 2026-04-02T07:19:30 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ncf4

📖 Wiki Page

gene2227 wordssynced 2026-04-02

title: NCF4 Gene

NCF4 (Neutrophil Cytosolic Factor 4)

| Property | Value |
|----------|-------|
| Gene Symbol | NCF4 |
| Full Name | Neutrophil Cytosolic Factor 4 (p40^phox^) |
| Chr Location | 22q13.1 |
| NCBI Gene ID | 3074 |
| OMIM ID | 604467 |
| Ensembl ID | ENSG00000100129 |
| UniProt ID | Q9UHI5 |
| Encoded Protein | p40^phox^ |
| Associated Diseases | Chronic Granulomatous Disease, Parkinson's Disease, Alzheimer's Disease, Inflammatory Diseases |

</div>

Overview

NCF4 (Neutrophil Cytosolic Factor 4), also known as p40^phox^, is a regulatory subunit of the NADPH oxidase (NOX2) complex that plays a critical role in generating reactive oxygen species (ROS) in phagocytic cells. While primarily studied in neutrophils and other immune cells, NCF4 is also expressed in microglia—the resident immune cells of the brain—where it contributes to neuroinflammatory processes that are central to neurodegenerative disease pathogenesis [1][2].

The NADPH oxidase complex is a multi-subunit enzyme that generates superoxide anion (O₂⁻) through the one-electron reduction of molecular oxygen.[@c2022] The p40^phox^ subunit serves as a critical positive regulator of this complex, enhancing oxidase activity in response to inflammatory stimuli. Genetic variants in NCF4 have been associated with altered risk for Parkinson's disease (PD), making it a gene of interest in neurodegenerative disease research [1].[@j2024]

Molecular Structure and Biochemistry

Protein Architecture

...

title: NCF4 Gene

NCF4 (Neutrophil Cytosolic Factor 4)

| Property | Value |
|----------|-------|
| Gene Symbol | NCF4 |
| Full Name | Neutrophil Cytosolic Factor 4 (p40^phox^) |
| Chr Location | 22q13.1 |
| NCBI Gene ID | 3074 |
| OMIM ID | 604467 |
| Ensembl ID | ENSG00000100129 |
| UniProt ID | Q9UHI5 |
| Encoded Protein | p40^phox^ |
| Associated Diseases | Chronic Granulomatous Disease, Parkinson's Disease, Alzheimer's Disease, Inflammatory Diseases |

</div>

Overview

NCF4 (Neutrophil Cytosolic Factor 4), also known as p40^phox^, is a regulatory subunit of the NADPH oxidase (NOX2) complex that plays a critical role in generating reactive oxygen species (ROS) in phagocytic cells. While primarily studied in neutrophils and other immune cells, NCF4 is also expressed in microglia—the resident immune cells of the brain—where it contributes to neuroinflammatory processes that are central to neurodegenerative disease pathogenesis [1][2].

The NADPH oxidase complex is a multi-subunit enzyme that generates superoxide anion (O₂⁻) through the one-electron reduction of molecular oxygen.[@c2022] The p40^phox^ subunit serves as a critical positive regulator of this complex, enhancing oxidase activity in response to inflammatory stimuli. Genetic variants in NCF4 have been associated with altered risk for Parkinson's disease (PD), making it a gene of interest in neurodegenerative disease research [1].[@j2024]

Molecular Structure and Biochemistry

Protein Architecture

The p40^phox^ protein is composed of several distinct domains that mediate its function:

PX Domain (1-80 aa): Phosphoinositide-binding module that targets p40^phox^ to cellular membranes and phagocytic vesicles
SH3 Domain (120-180 aa): Proline-rich region that mediates protein-protein interactions with other phox components
PCD Domain (200-280 aa): Protein interaction domain
C-terminal Region (280-339 aa): Regulatory domain controlling oxidase activity

The PX domain specifically binds to phosphatidylinositol 3-phosphate (PI3P), localizing p40^phox^ to early endosomes and phagosomes where NADPH oxidase assembly occurs [3].

The NADPH Oxidase Complex

The functional NADPH oxidase complex consists of five core components:

| Component | Gene | Function |
|-----------|------|----------|
| gp91^phox^ | CYBB | Catalytic subunit, forms the flavocytochrome b558 |
| p22^phox^ | CYBA | Stabilizes gp91^phox^, required for complex assembly |
| p47^phox^ | NCF1 | Cytosolic adaptor, organizes complex assembly |
| p67^phox^ | NCF2 | Cytosolic activator, contains activation domains |
| p40^phox^ | NCF4 | Positive regulator, enhances oxidase activity |

Regulatory Mechanisms

p40^phox^ enhances NADPH oxidase activity through several mechanisms:

Stabilization of the p67^phox^-p47^phox^ complex in the cytosol
Promotion of phagosomal localization
Interaction with the Rac GTPase
Phosphorylation-dependent activation

Physiological Functions

Immune System Function

In neutrophils, monocytes, and macrophages, p40^phox^ participates in the oxidative burst response:

Host Defense: Generates ROS that kill engulfed pathogens
Phagocytosis: Links NADPH oxidase activity to phagosome maturation
Signal Transduction: ROS serve as second messengers in inflammatory signaling

Microglial NOX Biology in the CNS

CNS Immune Surveillance

Microglia, the resident immune cells of the brain, serve as the first line of defense in the central nervous system [11]. The NADPH oxidase complex, including p40^phox^, is a critical component of microglial immune function:

Baseline ROS Production: Even in surveillance mode, microglia generate low levels of ROS for:

Signaling molecule production
Immune surveillance
Metabolic regulation
Synaptic remodeling

Activation-Induced Burst: Upon recognition of pathogens or damage signals, microglia undergo respiratory burst:

Rapid ROS production (100-1000x baseline)
Phagolysosome maturation
Pro-inflammatory cytokine release
Antigen presentation

NOX2 Complex Assembly

The NADPH oxidase complex requires precise spatial and temporal coordination [12][13]:

| Component | Activation Trigger | Translocation |
|-----------|-------------------|---------------|
| gp91^phox^/p22^phox^ | Pre-formed | Membrane (always) |
| p47^phox^ | Phosphorylation | Cytosol → Membrane |
| p67^phox^ | Phosphorylation | Cytosol → Membrane |
| p40^phox^ | Unknown signals | Endosome → Membrane |
| Rac GTPase | GDI dissociation | Cytosol → Membrane |

p40phox in Microglia

The specific role of p40^phox^ in microglial NADPH oxidase includes:

Endosomal Localization: p40^phox^ is enriched in microglial endosomes, creating a specialized ROS generation compartment

Sustained Activity: The p40^phox^ interaction stabilizes the active complex, extending ROS production

Signal Integration: p40^phox^ integrates multiple signaling inputs for regulated ROS production

Phagocytosis Coupling: Links ROS generation to phagocytic activity

Role in Alzheimer's Disease Pathogenesis

Amyloid-Beta-Mediated Activation

Multiple studies have demonstrated that amyloid-beta (Aβ) peptides directly activate microglial NADPH oxidase [6][14][15]:

Direct Activation:

Aβ binds to microglial receptors (TLRs, RAGE)
Initiates intracellular signaling cascades
Leads to p47^phox^ phosphorylation
Promotes NOX complex assembly

Amplification Loops:

Aβ-induced ROS increases Aβ aggregation
More Aβ leads to more microglial activation
Creates feed-forward neurotoxic cycle

Tau Pathology Connection

NADPH oxidase activation also connects to tau pathology [15]:

ROS can directly modify tau proteins
Promotes tau phosphorylation
Facilitates tau aggregation
Accelerates NFT formation

Therapeutic Implications

Targeting NADPH oxidase in AD has shown promise [9][16][17]:

Benefits of NOX Inhibition:

Reduced oxidative stress
Decreased neuroinflammation
Improved cognitive function in animal models
Potential disease modification

Challenges:

Maintaining physiological ROS functions
CNS penetration of inhibitors
Timing of intervention
Specificity for disease-related activation

Role in Parkinson's Disease Pathogenesis

SNpc Vulnerability

The substantia nigra pars compacta (SNpc) has unique vulnerabilities to NADPH oxidase-mediated damage [1]:

Microglial Density: High microglial density in SNpc Environmental Exposure: Direct exposure to blood-borne immune cells Metabolic Stress: High metabolic demand increases baseline oxidative stress

Genetic Evidence

The GWAS association of NCF4 with PD provides direct evidence [1]:

NCF4 rs1883126 associated with increased PD risk
Effect size: OR ~1.15 per risk allele
Mechanistic plausibility through enhanced microglial ROS

###alpha-Synuclein Interaction

NADPH oxidase interacts with alpha-synuclein pathology:

α-synuclein aggregates activate microglia
Activated microglia produce ROS
ROS promotes further α-synuclein aggregation
Creates vicious cycle of neurodegeneration

Signaling Pathways and Regulation

Upstream Activation Signals

p40^phox^ activation is regulated by multiple inputs:

| Signal | Mechanism | Effect |
|--------|-----------|--------|
| TLR ligands | MyD88-dependent | Potent activation |
| Cytokines (IFN-γ, TNF-α) | JAK/STAT | Enhanced expression |
| ATP/P2X7 receptors | Calcium influx | Assembly promotion |
| α-synuclein aggregates | Pattern recognition | Chronic activation |
| Aβ peptides | Multiple receptors | Sustained activation |

Negative Regulation

Several mechanisms constrain NADPH oxidase:

SOCS proteins: Suppress cytokine signaling
Antioxidants: Scavenge ROS (glutathione, SOD)
PI3K signaling: Promotes p40^phox^ degradation
Anti-inflammatory cytokines: IL-10, TGF-β

NOX2 in Neuroinflammation

The complete NOX2 complex (gp91^phox^ = CYBB) is the catalytic core [10]:

CYBB deficiency in mice reduces neuroinflammation
NOX2 deletion protects dopaminergic neurons
NOX2 deficiency improves motor function in PD models

Chronic Granulomatous Disease (CGD)

NCF4 Mutations

NCF4 is one of several genes causing CGD [11]:

| Gene | Protein | Inheritance | Phenotype |
|------|---------|-------------|-----------|
| CYBB | gp91^phox^ | X-linked | Severe |
| CYBA | p22^phox^ | Autosomal | Moderate |
| NCF1 | p47^phox^ | Autosomal | Moderate |
| NCF2 | p67^phox^ | Autosomal | Moderate |
| NCF4 | p40^phox^ | Autosomal | Mild |

NCF4-Specific Features

NCF4-related CGD has distinct features:

Milder phenotype: Residual oxidase activity
Late onset: Often presents in adolescence
Atypical infections: More fungal infections
Inflammatory complications: Granuloma formation

Treatment Considerations

Antimicrobial prophylaxis
Interferon-gamma therapy
Gene therapy potential
Stem cell transplantation

Research Methods and Tools

Biochemical Approaches

Lucigenin/cytochrome c assay: Measure superoxide production
DHE fluorescence: ROS detection in cells
Immunoprecipitation: Complex assembly studies
Western blotting: Protein expression and phosphorylation

Cellular Models

BV-2 microglia: Immortalized mouse microglia
Primary microglia: From rodent brain
iPSC-derived microglia: Human models
Co-culture systems: Neuron-microglia cultures

Animal Models

NCF4 knockout mice: For loss-of-function studies
Transgenic models: Conditional NOX expression
PD models: MPTP, 6-OHDA
AD models: APP/PS1, 3xTg

Therapeutic Targeting Strategies

NOX1/NOX4 Selective Inhibitors

| Compound | Target | Stage |
|----------|--------|-------|
| GKT137831 | NOX1/NOX4 | Phase 2 trials |
| Setanaxib | NOX1/NOX4 | Clinical trials |
| ML171 | NOX1 selective | Preclinical |
| GSK2795039 | NOX2 | Preclinical |

Repositioned Drugs

Several existing drugs have NOX-inhibitory properties:

Fingolimod: Modulates NOX activity
Statins: Pleiotropic anti-ROS effects
Minocycline: Anti-inflammatory beyond antibiotic

Combination Approaches

NOX inhibition + anti-inflammatory
NOX inhibition + antioxidant
NOX inhibition + neuroprotective

Evolutionary Perspective

Gene Family Evolution

NCF4 and other phox genes evolved from ancestral NADPH oxidases [4]:

Ancient NOX predates metazoan divergence
Duplication created multiple isoforms
NCF4 emerged specifically in vertebrates
Adaptive evolution in immune genes

Comparative Studies

Model organisms reveal conserved functions:

Zebrafish: NCF4 in embryonic immunity
Drosophila: Homologs in phagocytosis
C. elegans: NOX in host defense

Biomarker Potential

NCF4 Expression as Marker

NCF4 expression may serve as biomarker:

Increased in neurodegenerative disease brains
Correlates with disease severity
Potential for disease monitoring

Therapeutic Response Marker

NOX activity could monitor treatment response:

Reduced NCF4 expression with therapy
Decreased ROS production
Improved outcomes

Role in Neurodegenerative Diseases

Parkinson's Disease

Genetic association studies have identified NCF4 variants as risk factors for Parkinson's disease [1]. The mechanism involves:

Enhanced Microglial Activation: Certain NCF4 variants may increase NADPH oxidase activity

Excessive ROS Production: Heightened oxidative stress in the substantia nigra

Dopaminergic Neuron Vulnerability: ROS-mediated damage to vulnerable dopaminergic neurons

Neuroinflammation: Amplification of inflammatory responses

The study by Gao et al. (2018) demonstrated that NCF4 polymorphisms contribute to PD risk, highlighting the importance of microglial NADPH oxidase in disease pathogenesis [1].

Alzheimer's Disease

Multiple studies have documented NADPH oxidase activation in Alzheimer's disease brains [6][7][8]:

Amyloid-Beta Activation: Aβ peptides stimulate microglial NADPH oxidase
Oxidative Stress: Increased ROS production in AD brain tissue
Neuroinflammation: Amplified inflammatory responses through ROS signaling
Neuronal Damage: ROS contribute to synaptic dysfunction and neuronal loss

Block (2008) proposed NADPH oxidase as a therapeutic target in AD, recognizing that inhibiting excessive ROS production while preserving host defense could provide neuroprotective benefits [9].

NOX2 in AD and PD

Recent research by Dustin et al. (2024) provides comprehensive evidence for NOX2 (the catalytic subunit of NADPH oxidase) involvement in both Alzheimer's and Parkinson's diseases [10]. Key findings include:

Elevated NOX2 expression in disease brains
Correlation with disease severity
Therapeutic potential of NOX inhibitors

Chronic Granulomatous Disease

Genetic Basis

NCF4 mutations cause a rare form of Chronic Granulomatous Disease (CGD), characterized by defective NADPH oxidase function [11]. Unlike other CGD-causing genes (CYBB, CYBA, NCF1, NCF2), NCF4 deficiency presents with a milder phenotype due to residual oxidase activity.

Clinical Features

Recurrent infections with catalase-positive bacteria
Impaired wound healing
Granuloma formation
Inflammatory complications

Expression Pattern

Immune Cell Expression

Neutrophils: Highest expression, primary cell type
Monocytes/Macrophages: Significant expression
Dendritic Cells: Moderate expression

Brain Expression

Microglia: Primary source in the CNS
Expression is Dynamic: Increases in response to neuroinflammatory stimuli

Therapeutic Targeting

NADPH Oxidase Inhibitors

Several strategies are being explored to target the NADPH oxidase complex:

| Agent | Mechanism | Development Stage |
|-------|-----------|-------------------|
| GKT137831 | Selective NOX1/NOX4 inhibitor | Clinical trials |
| Apocynin | Prevents assembly | Preclinical |
| DPI | Flavoprotein inhibitor | Research tool |

Therapeutic Considerations

Selective Inhibition: Targeting specific NOX isoforms to preserve host defense
BBB Penetration: Ensuring CNS delivery for neuroprotection
Combination Therapy: Synergy with anti-inflammatory agents

External Links

[NCBI Gene: NCF4](https://www.ncbi.nlm.nih.gov/gene/3074)
[UniProt: Q9UHI5](https://www.uniprot.org/uniprot/Q9UHI5)
[OMIM: 604467](https://www.omim.org/entry/604467)
[Ensembl: ENSG00000100129](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100129)

References

[Gao et al., NCF4 variants and Parkinson's disease risk (2018)](https://pubmed.ncbi.nlm.nih.gov/30506947/)

[Simpson & Oliver, ROS Generation in Microglia: Oxidative Stress and Inflammation in Neurodegenerative Disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32823544/)

[Kuribayashi et al., The adaptor protein p40phox as a positive regulator of the superoxide-producing phagocyte oxidase (2002)](https://pubmed.ncbi.nlm.nih.gov/12456638/)

[Wilkinson & Landreth, The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease (2006)](https://pubmed.ncbi.nlm.nih.gov/17094809/)

[Shimohama et al., Activation of NADPH oxidase in Alzheimer's disease brains (2000)](https://pubmed.ncbi.nlm.nih.gov/10873554/)

[Block, NADPH oxidase as a therapeutic target in Alzheimer's disease (2008)](https://pubmed.ncbi.nlm.nih.gov/19090996/)

[Fragoso-Morales et al., NADPH Oxidase and Its Inhibitors in Alzheimer's Disease Murine Models (2021)](https://pubmed.ncbi.nlm.nih.gov/33540840/)

[Zhan et al., Cloning and chromosomal localization of ncf4 (1997)](https://pubmed.ncbi.nlm.nih.gov/8995189/)

[Tarazona-Santos et al., Evolutionary dynamics of the human NADPH oxidase genes (2013)](https://pubmed.ncbi.nlm.nih.gov/23821607/)

[Dustin et al., NOX2 in Alzheimer's and Parkinson's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/39616884/)

[Yu et al., Chronic Granulomatous Disease: a Comprehensive Review (2021)](https://pubmed.ncbi.nlm.nih.gov/32524254/)

[Fanucchi et al., Phagocyte NADPH oxidase: a major player in CNS innate immunity (2011)](https://pubmed.ncbi.nlm.nih.gov/21606684/)

[Sorce & Krause, NOX enzymes in the central nervous system: from signaling to disease (2012)](https://pubmed.ncbi.nlm.nih.gov/22903897/)

[Jayaraman et al., p40phox: the novel NADPH oxidase component (2011)](https://pubmed.ncbi.nlm.nih.gov/21219714/)

[Choi et al., NADPH oxidase in Alzheimer's disease and tauopathy (2012)](https://pubmed.ncbi.nlm.nih.gov/22727728/)

[Mall et al., Role of p40phox in host defense against pathogens (2013)](https://pubmed.ncbi.nlm.nih.gov/23588628/)

📖 View canonical wiki page →

Related Entities

NCF4

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ncf4
kg_node_id	NCF4
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-44a28664ed68
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ncf4'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

5%

Debates

0

Incoming

1

Outgoing

2

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NCF4 (Neutrophil Cytosolic Factor 4)

NCF4 (Neutrophil Cytosolic Factor 4)

Overview

Molecular Structure and Biochemistry

Protein Architecture

NCF4 (Neutrophil Cytosolic Factor 4)

Overview

Molecular Structure and Biochemistry

Protein Architecture

The NADPH Oxidase Complex

Regulatory Mechanisms

Physiological Functions

Immune System Function

Microglial NOX Biology in the CNS

CNS Immune Surveillance

NOX2 Complex Assembly

p40phox in Microglia

Role in Alzheimer's Disease Pathogenesis

Amyloid-Beta-Mediated Activation

Tau Pathology Connection

Therapeutic Implications

Role in Parkinson's Disease Pathogenesis

SNpc Vulnerability

Genetic Evidence

Signaling Pathways and Regulation

Upstream Activation Signals

Negative Regulation

NOX2 in Neuroinflammation

Chronic Granulomatous Disease (CGD)

NCF4 Mutations

NCF4-Specific Features

Treatment Considerations

Research Methods and Tools

Biochemical Approaches

Cellular Models

Animal Models

Therapeutic Targeting Strategies

NOX1/NOX4 Selective Inhibitors

Repositioned Drugs

Combination Approaches

Evolutionary Perspective

Gene Family Evolution

Comparative Studies

Biomarker Potential

NCF4 Expression as Marker

Therapeutic Response Marker

Role in Neurodegenerative Diseases

Parkinson's Disease

Alzheimer's Disease

NOX2 in AD and PD

Chronic Granulomatous Disease

Genetic Basis

Clinical Features

Expression Pattern

Immune Cell Expression

Brain Expression

Therapeutic Targeting

NADPH Oxidase Inhibitors

Therapeutic Considerations

See Also

External Links

References

💬 Discussion